HIV 感染者中的结核分枝杆菌感染：挑战与对策。
Tuberculosis Infection in People Living with Human Immunodeficiency Virus: Challenges and Solutions.
机构信息
Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
出版信息
Viruses. 2024 Aug 14;16(8):1295. doi: 10.3390/v16081295.
Abstract
The findings by Pipitò et al [...].
摘要
皮皮托等人的研究结果[...]。
相似文献
1
Tuberculosis Infection in People Living with Human Immunodeficiency Virus: Challenges and Solutions.HIV 感染者中的结核分枝杆菌感染：挑战与对策。
Viruses. 2024 Aug 14;16(8):1295. doi: 10.3390/v16081295.
2
Tuberculosis in patients with human immunodeficiency virus infection.人类免疫缺陷病毒感染患者的结核病
N Engl J Med. 1991 Jun 6;324(23):1644-50. doi: 10.1056/NEJM199106063242307.
3
Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.人类免疫缺陷病毒1型包膜中HLA - DR在体内的整合：与疾病阶段及机会性感染存在情况的相关性
J Virol. 2000 Nov;74(21):10256-9. doi: 10.1128/jvi.74.21.10256-10259.2000.
4
Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus co-infection.三重困境：营养不良在结核病与人类免疫缺陷病毒合并感染中的作用
Nutr Rev. 2003 Mar;61(3):81-90. doi: 10.1301/nr.2003.marr.81-90.
5
Worms and pediatric human immunodeficiency virus infection and tuberculosis.蠕虫与儿童人类免疫缺陷病毒感染及结核病
J Infect Dis. 2000 May;181(5):1873. doi: 10.1086/315417.
6
Impact of HIV infection on mycobacterial disease.HIV感染对分枝杆菌病的影响。
Am Fam Physician. 1992 May;45(5):2203-11.
7
Treatment outcome of tuberculosis among Human Immunodeficiency Virus positive patients in Eastern Ethiopia: a retrospective study.埃塞俄比亚东部人类免疫缺陷病毒阳性患者的结核病治疗结果：一项回顾性研究。
Pan Afr Med J. 2018 May 16;30:32. doi: 10.11604/pamj.2018.30.32.12554. eCollection 2018.
8
Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an update.HIV 感染者中药物敏感性结核病的治疗：更新。
Curr Opin HIV AIDS. 2018 Nov;13(6):469-477. doi: 10.1097/COH.0000000000000506.
9
Abdominal tuberculosis in patients infected with the human immunodeficiency virus.感染人类免疫缺陷病毒患者的腹部结核
Clin Infect Dis. 1995 Apr;20(4):938-44. doi: 10.1093/clinids/20.4.938.
10
Safety and Efficacy of Rifampin or Isoniazid Among People With Mycobacterium tuberculosis Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials.利福平或异烟肼在结核分枝杆菌感染且合并人类免疫缺陷病毒或其他健康状况人群中的安全性和疗效：2 项随机试验的事后分析。
Clin Infect Dis. 2021 Nov 2;73(9):e3545-e3554. doi: 10.1093/cid/ciaa1169.
本文引用的文献
1
Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study.HIV 感染者潜伏性结核病感染筛查：TUBHIVIT 项目，一项多中心意大利研究。
Viruses. 2024 May 14;16(5):777. doi: 10.3390/v16050777.
2
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.利福平治疗婴儿中多替拉韦的每日 2 次给药：EMPIRICAL 试验的药代动力学子研究。
Clin Infect Dis. 2024 Mar 20;78(3):702-710. doi: 10.1093/cid/ciad656.
3
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.美国指南在短程结核病预防疗法方面存在不足。
Clin Infect Dis. 2024 Mar 20;78(3):514-517. doi: 10.1093/cid/ciad659.
4
Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.成人潜伏性结核感染筛查：美国预防服务工作组的更新证据报告及系统评价
JAMA. 2023 May 2;329(17):1495-1509. doi: 10.1001/jama.2023.3954.
5
Diagnostic accuracy of the interferon-gamma release assay in acquired immunodeficiency syndrome patients with suspected tuberculosis infection: a meta-analysis.γ-干扰素释放试验在疑似结核感染获得性免疫缺陷综合征患者中的诊断准确性：一项荟萃分析。
Infection. 2022 Jun;50(3):597-606. doi: 10.1007/s15010-022-01789-9. Epub 2022 Mar 6.
6
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.每周一次利福喷丁和异烟肼用于接受多替拉韦为基础的抗反转录病毒治疗的 HIV 感染者的结核病预防：一项 1/2 期试验。
Lancet HIV. 2020 Jun;7(6):e401-e409. doi: 10.1016/S2352-3018(20)30032-1. Epub 2020 Mar 30.
7
Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial.基于多替拉韦的抗反转录病毒疗法治疗结核分枝杆菌与人类免疫缺陷病毒合并感染患者：一项多中心、非对照、开放标签、随机试验。
Clin Infect Dis. 2020 Feb 3;70(4):549-556. doi: 10.1093/cid/ciz256.
8
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.成人潜伏性结核：利福平治疗 4 个月或异烟肼治疗 9 个月。
N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.
9
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.潜伏性结核感染的全球负担：使用数学模型的重新估计
PLoS Med. 2016 Oct 25;13(10):e1002152. doi: 10.1371/journal.pmed.1002152. eCollection 2016 Oct.
10
Treatment of latent tuberculosis infection: a network meta-analysis.潜伏性结核感染的治疗：一项网络荟萃分析。
Ann Intern Med. 2014 Sep 16;161(6):419-28. doi: 10.7326/M14-1019.
Zotero 插件